• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ciclosporin (CicloMulsion) for reperfusion injury prevention prior to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction
2014     HAYES, Inc. Roux-en-Y gastric bypass for diabetes in obese or severely obese patients
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Alogliptin/metformin (Vipdomet®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of massive blood transfusion in the rural setting: guidelines
2014     Malaysian Health Technology Assessment (MaHTAS) Ultrasonic wound debridement device
2014     National Institute for Health and Care Excellence (NICE) Dimethyl fumarate for treating relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 320
2014     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human alpha-mannosidase (Lamazym) for alpha mannosidosis
2014     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: Simeprevir
2014     Belgian Health Care Knowledge Centre (KCE) Caring for mothers and newborns after uncomplicated delivery: towards integrated postnatal care
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Cryotherapy systems for wart removal: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014     Malaysian Health Technology Assessment (MaHTAS) Pulse oximetry screening for critical congenital heart disease in newborn infants
2014     National Institute for Health and Care Excellence (NICE) Dabrafenib for treating unresectable or metastatic BRAF V600 mutation positive melanoma. NICE technology appraisal guidance 321
2014     NIHR Health Technology Assessment programme A modelled analysis using data from the ARTISTIC trial of the potential effectiveness and cost-effectiveness of HPV testing in cervical cancer screening
2014     NIHR Horizon Scanning Centre (NIHR HSC) Metreleptin for generalised and partial lipodystrophy
2014     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: Sofosbuvir and Ledipasvir
2014     Belgian Health Care Knowledge Centre (KCE) Management of autism in children and young people: a good clinical practice guideline
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Jewellery and the risk of bacteria transmission from healthcare worker to patient: clinical evidence
2014     Malaysian Health Technology Assessment (MaHTAS) Piston-type mechanical chest compression
2014     National Institute for Health and Care Excellence (NICE) Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality. NICE technology appraisal guidance 322
2014     NIHR Health Technology Assessment programme T-DM1 for treating HER2-positive, unresectable locally advanced or metastatic breast cancer after treatment with trastuzumab and a taxane
2014     NIHR Horizon Scanning Centre (NIHR HSC) myVisionTrack® for monitoring degenerative eye disease
2014     HAYES, Inc. ß-D-glucan assay for detection of invasive fungal disease
2014     NIHR Health Technology Assessment programme The use of fenestrated and branched endovascular aneurysm repair for juxtarenal and thoracoabdominal aneurysms: a systematic review and cost-effectiveness analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intranasal versus intravenous naloxone for opioid overdose in the pre-hospital setting: comparative clinical effectiveness
2014     National Institute for Health and Care Excellence (NICE) Erythropoiesis stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy. NICE technology appraisal guidance 323
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tabalumab for systemic lupus erythematosus
2014     HAYES, Inc. Ultrasound-guided injections of joints of the extremities
2014     NIHR Health Services and Delivery Research programme Organisational interventions to reduce length of stay in hospital: a rapid evidence assessment
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intrathecal bupivacaine via infusion pump for the management of pain: clinical evidence, safety, and guidelines
2014     HTA Unit, University of Calgary Repetitive transcranial magnetic stimulation for treatment resistant depression
2014     Malaysian Health Technology Assessment (MaHTAS) Inexscreen as a screening test for ectopic pregnancy and miscarriage
2014     National Institute for Health and Care Excellence (NICE) Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block. NICE technology appraisal guidance 324
2014     NIHR Horizon Scanning Centre (NIHR HSC) SafePlace for the peripheral insertion of central venous catheters in infants
2014     HAYES, Inc. Upright magnetic resonance imaging for diagnosis of spinal disorders
2014     NIHR Health Services and Delivery Research programme A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions: PRISMS - Practical systematic RevIew of Self-Management Support for long-term conditions
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Electromagnetic interference between healthcare laser systems and sensitive electronic devices: safety and guidelines
2014     HTA Unit, University of Calgary Best practices in the management of behavioural and psychological symptoms of dementia in residents of long-term care facilities in Alberta
2014     Malaysian Health Technology Assessment (MaHTAS) Extracorporeal Shockwave Myocardial Revascularization (ESMR)
2014     National Institute for Health and Care Excellence (NICE) Nalmefene for reducing alcohol consumption in people with alcohol dependence. NICE technology appraisal guidance 325
2014     NIHR Horizon Scanning Centre (NIHR HSC) Interferon beta-1a (Traumakine) for acute respiratory distress syndrome – first line
2014     HAYES, Inc. CBJ test GTE report with evidence table
2014     NIHR Health Services and Delivery Research programme Reducing Care Utilisation through Self-management Interventions (RECURSIVE): a systematic review and meta-analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Radiation emissions from computed tomography: a review of the risk of cancer and guidelines
2014     Malaysian Health Technology Assessment (MaHTAS) T.SPOT.TB assay – an update
2014     National Institute for Health and Care Excellence (NICE) Imatinib for the adjuvant treatment of gastrointestinal stromal tumours. NICE technology appraisal guidance 326
2014     National Institute for Health and Care Excellence (NICE) Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system). NICE diagnostics guidance 14
2014     NIHR Horizon Scanning Centre (NIHR HSC) Mepolizumab for severe refractory eosinophilic asthma – first line
2014     HAYES, Inc. CHARGE syndrome
2014     NIHR Health Services and Delivery Research programme Learning for the NHS on procurement and supply chain management: a rapid evidence assessment
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014     Malaysian Health Technology Assessment (MaHTAS) Computer assisted surgery for unicondylar and total knee replacement
2014     National Institute for Health and Care Excellence (NICE) Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism. NICE technology appraisal guidance 327
2014     NIHR Horizon Scanning Centre (NIHR HSC) Brodalumab for moderate to severe plaque psoriasis
2014     HAYES, Inc. Corus CAD
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Review of positron emission tomography (PET) indications. Appropriate use criteria]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Waterless wipes for chemical eye injuries: clinical effectiveness
2014     Malaysian Health Technology Assessment (MaHTAS) Acupuncture for chemotherapy-induced nausea and vomiting in cancer patients
2014     Andalusian Health Technology Assessment Area (AETSA) Digital tomosynthesis in breast cancer. Systematic Review
2014     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of treatment with renal denervation for patients with resistant hypertension?
2014     Agency for Healthcare Research and Quality (AHRQ) Prevention of dental caries in children younger than 5 years old: systematic review to update the U.S. Preventive Services Task Force Recommendation
2014     HAYES, Inc. Molecular/cytogenetic testing for diagnosis and prognosis in primary/de novo acute myeloid leukemia (AML)
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Comparative effectiveness of conservative treatment of breast cancer with brachytherapy and external beam radiation]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014     Andalusian Health Technology Assessment Area (AETSA) Anti TNF alpha drugs for adults with moderate to severe non fistulizing active Chron's disease.
2014     NIHR Health Technology Assessment programme A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia
2014     Health Council of the Netherlands Gezondheidsraad (GR) Population screening for breast cancer: expectations and developments
2014     HAYES, Inc. Myeloma prognostic risk signature (MyPRS) test for myeloma
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Efficacy and safety of hip resurfacing versus traditional total hip arthroplasty]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Therapeutic recreation for elderly and mental health patients: clinical benefit, safety, and guidelines
2014     Andalusian Health Technology Assessment Area (AETSA) Real-time 3D Transesophageal Echocardiography (RT-3D-TEE) versus 2D.
2014     NIHR Health Technology Assessment programme Sofosbuvir for treating chronic hepatitis C
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Judicious use of 14 laboratory tests]
2014     Health Council of the Netherlands Gezondheidsraad (GR) Criteria for the selection of a vaccine against pertussis
2014     HAYES, Inc. OVA1 ovarian tumor triage test
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Emergency medical service "treat and release" protocols: a review of clinical and cost-effectiveness, safety, and guidelines
2014     Malaysian Health Technology Assessment (MaHTAS) Pneumococcal conjugate vaccine for children below five years old
2014     Andalusian Health Technology Assessment Area (AETSA) Incompatible living donor kidney transplantation.
2014     NIHR Health Technology Assessment programme Lubiprostone for chronic idiopathic constipation [ID725]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [ETIAMEST I & II: Highlights]
2014     Health Council of the Netherlands Gezondheidsraad (GR) Fighting the flu
2014     HAYES, Inc. PALB2-associated hereditary breast cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014     Malaysian Health Technology Assessment (MaHTAS) Continuous intrathecal baclofen (ITB) infusion for severe spasticity and dystonia
2014     Andalusian Health Technology Assessment Area (AETSA) Ranizumab and bevacizumab for the treatment of diabetic macular oedema.
2014     NIHR Health Technology Assessment programme Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Facility planning and infection prevention: sanitary facilities in specialized care rooms and cubicles]
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [How to improve the management of depression? A qualitative approach]
2014     HAYES, Inc. CyberKnife robotic radiosurgery system (Accuray Inc.) for treatment of prostate cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014     Andalusian Health Technology Assessment Area (AETSA) Lumbar total disc replacement effectiveness and safety in chronic low back pain.
2014     NIHR Health Technology Assessment programme Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neonatal screening for classic galactosemia. Systematic review]
2014     HAYES, Inc. Endoscope-based confocal laser endomicroscopy for surveillance in patients with Barrett's esophagus
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous fat grafting for reconstructive surgery: a review of the clinical and cost-effectiveness
2014     Andalusian Health Technology Assessment Area (AETSA) Efficacy and safety of kyphoplasty and vertebroplasty in osteoporotic vertebral compression fracture.
2014     NIHR Health Technology Assessment programme Abiraterone acetate for the treatment of chemotherapy naive metastatic castration-resistant prostate cancer (ID503)
2014     HAYES, Inc. Intra-articular injection of cross-linked hyaluronans for treatment of shoulder osteoarthritis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2014     Malaysian Health Technology Assessment (MaHTAS) Bronchial thermoplasty
2014     Andalusian Health Technology Assessment Area (AETSA) Effectiveness and safety of interspinous devices